{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:10:57Z","timestamp":1776773457008,"version":"3.51.2"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,14]],"date-time":"2015-03-14T00:00:00Z","timestamp":1426291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-0862-7","type":"journal-article","created":{"date-parts":[[2015,3,13]],"date-time":"2015-03-13T15:08:01Z","timestamp":1426259281000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children"],"prefix":"10.1186","volume":"15","author":[{"given":"Aparna","family":"Mukherjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thirumurthy","family":"Velpandian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohit","family":"Singla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunwar","family":"Kanhiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushil K","family":"Kabra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Lodha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,14]]},"reference":[{"key":"862_CR1","volume-title":"Global tuberculosis report","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. Global tuberculosis report. Geneva, Switzerland: World Health Organization; 2013."},{"key":"862_CR2","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1086\/429321","volume":"40","author":"M Weiner","year":"2005","unstructured":"Weiner M, Benator D, Burman W, Peloquin CA, Khan A, Vernon A. Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis. Clin Infect Dis. 2005;40:1481\u201391.","journal-title":"Clin Infect Dis"},{"key":"862_CR3","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1164\/rccm.200208-951OC","volume":"167","author":"M Weiner","year":"2003","unstructured":"Weiner M, Burman W, Vernon A, Benator D, Peloquin CA, Khan A. Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine. Am J RespirCrit Care Med. 2003;167:1341\u20137.","journal-title":"Am J RespirCrit Care Med"},{"key":"862_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00007611-200093050-00015","volume":"93","author":"RS Morehead","year":"2000","unstructured":"Morehead RS. Delayed death from pulmonary tuberculosis: unsuspected subtherapeutic drug levels. South Med J. 2000;93:507\u201310.","journal-title":"South Med J"},{"key":"862_CR5","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1378\/chest.120.5.1520","volume":"120","author":"JB Mehta","year":"2001","unstructured":"Mehta JB, Shantaveerapa H, Byrd Jr RP, Morton SE, Fountain F, Roy TM. Utility of rifampin blood levels in the treatment and follow-up of active pulmonary tuberculosis in patients who were slow to respond to routine directly observed therapy. Chest. 2001;120:1520\u20134.","journal-title":"Chest"},{"key":"862_CR6","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1136\/adc.2004.052175","volume":"90","author":"HS Schaaf","year":"2005","unstructured":"Schaaf HS, Parkin DP, Seifart HI, Werely CJ, Hesseling PB, Van Helden PD. Isoniazid pharmacokinetics in children treated for respiratory tuberculosis. Arch Dis Child. 2005;90:614\u20138.","journal-title":"Arch Dis Child"},{"key":"862_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1741-7015-7-19","volume":"7","author":"HS Schaaf","year":"2009","unstructured":"Schaaf HS, Willemse M, Cilliers K, Labadarios D, Maritz JS, Hussey GD. Rifampin pharmacokinetics in children, with and without human immunodeficiency virus infection, hospitalized for the management of severe forms of tuberculosis. BMC Med. 2009;7:19.","journal-title":"BMC Med"},{"key":"862_CR8","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1086\/598192","volume":"48","author":"H McIlleron","year":"2009","unstructured":"McIlleron H, Willemse M, Werely CJ, Hussey GD, Schaaf HS, Smith PJ. Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines. Clin Infect Dis. 2009;48:1547\u201353.","journal-title":"Clin Infect Dis"},{"key":"862_CR9","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/INF.0b013e3181fbefe1","volume":"30","author":"H McIlleron","year":"2011","unstructured":"McIlleron H, Willemse M, Schaaf HS, Smith PJ, Donald PR. Pyrazinamide plasma concentrations in young children with tuberculosis. Pediatr Infect Dis J. 2011;30:262\u20135.","journal-title":"Pediatr Infect Dis J"},{"key":"862_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1128\/AAC.50.2.407-413.2006","volume":"50","author":"SM Graham","year":"2006","unstructured":"Graham SM, Bell DJ, Nyirongo S, Hartkoorn R, Ward SA, Molyneux EM. Low levels of pyrazinamide and ethambutol in children with tuberculosis and impact of age, nutritional status, and human immunodeficiency virus infection. Antimicrob Agents Chemother. 2006;50:407\u201313.","journal-title":"Antimicrob Agents Chemother"},{"key":"862_CR11","volume-title":"Report of the meeting on TB medicines for children","author":"World Health Organization","year":"2008","unstructured":"World Health Organization. Report of the meeting on TB medicines for children. Geneva, Switzerland: WHO; 2008."},{"key":"862_CR12","volume-title":"Rapid Advice Treatment of tuberculosis in children","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. Rapid Advice Treatment of tuberculosis in children. Geneva, Switzerland: WHO, Geneva, Switzerland; 2010."},{"key":"862_CR13","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00228-010-0851-0","volume":"66","author":"KA Oshikoya","year":"2010","unstructured":"Oshikoya KA, Sammons HM, Choonara I. A systematic review of pharmacokinetics studies in children with protein-energy malnutrition. Eur J ClinPharmacol. 2010;66:1025\u201335.","journal-title":"Eur J ClinPharmacol"},{"key":"862_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1743-7075-6-50","volume":"6","author":"KA Oshikoya","year":"2009","unstructured":"Oshikoya KA, Senbanjo IO. Pathophysiological changes that affect drug disposition in protein-energy malnourished children. Nutr Metab. 2009;6:50.","journal-title":"Nutr Metab"},{"key":"862_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/00005176-198302030-00004","volume":"2","author":"S Mehta","year":"1983","unstructured":"Mehta S. Drug disposition in children with protein energy malnutrition. J Pediatr Gastroenterol Nutr. 1983;2:407\u201317.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"862_CR16","doi-asserted-by":"publisher","first-page":"800","DOI":"10.5588\/ijtld.12.0628","volume":"17","author":"G Ramachandran","year":"2013","unstructured":"Ramachandran G, Hemanth Kumar AK, Bhavani PK, Poorana Gangadevi N, Sekar L. Age, nutritional status and INH acetylator status affect pharmacokinetics of anti-tuberculosis drugs in children. Int J Tuberc Lung Dis. 2013;17:800\u20136.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"862_CR17","first-page":"840","volume":"110","author":"A Kumar","year":"2012","unstructured":"Kumar A, Gupta D, Nagaraja SB, Singh V, Sethi GR, Prasad J, et al. Updated current (2012) national guidelines for paediatric tuberculosis in India. J Indian Med Assoc. 2012;110(11):840\u20135.","journal-title":"J Indian Med Assoc"},{"key":"862_CR18","unstructured":"Centers for Disease Control and Prevention. Growth Charts - 2000 CDC Growth Charts. CDC.gov. 2013. Available from: http:\/\/www.cdc.gov\/growthcharts\/cdc_charts.htm, Accessed on: 10th Aug, 2014."},{"key":"862_CR19","volume-title":"Management of severe malnutrition: a Manual for Physicians and Other Senior Health Workers","author":"World Health Organization","year":"1999","unstructured":"World Health Organization. Management of severe malnutrition: a Manual for Physicians and Other Senior Health Workers. Geneva, Switzerland: WHO; 1999."},{"key":"862_CR20","first-page":"901","volume":"41","author":"LS Chauhan","year":"2004","unstructured":"Chauhan LS, Arora VK. Management of pediatric tuberculosis under the Revised National Tuberculosis Control Program (RNTCP). Indian Pediatr. 2004;41:901\u20135.","journal-title":"Indian Pediatr"},{"key":"862_CR21","first-page":"927","volume":"41","author":"SK Kabra","year":"2004","unstructured":"Kabra SK, Lodha R, Seth V. Category based treatment of tuberculosis in children. Indian Pediatr. 2004;41:927\u201337.","journal-title":"Indian Pediatr"},{"key":"862_CR22","volume-title":"Guidance for National Tuberculosis Programmes on the management of tuberculosis in children","author":"World Health Organization","year":"2006","unstructured":"World Health Organization. Guidance for National Tuberculosis Programmes on the management of tuberculosis in children. Geneva, Switzerland: World Health Organization; 2006."},{"key":"862_CR23","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/clinchem\/23.4.745","volume":"23","author":"WA Olson","year":"1977","unstructured":"Olson WA, Dayton PG, Israili ZH, Pruitt AW. Spectrophotofluorometric assay for isoniazid and acetyl isoniazid in plasma adapted to pediatric studies. Clin Chem. 1977;23:745\u20138.","journal-title":"Clin Chem"},{"key":"862_CR24","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.2165\/00003495-200262150-00001","volume":"62","author":"CA Peloquin","year":"2002","unstructured":"Peloquin CA. Therapeutic drug monitoring in the treatment of tuberculosis. Drugs. 2002;62:2169\u201383.","journal-title":"Drugs"},{"key":"862_CR25","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1136\/jmg.34.9.758","volume":"34","author":"CA Smith","year":"1997","unstructured":"Smith CA, Wadelius M, Gough AC, Harrison DJ, Wolf CR, Rane A. A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid. J Med Genet. 1997;34:758\u201360.","journal-title":"J Med Genet"},{"key":"862_CR26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2165\/00044011-200323070-00005","volume":"23","author":"J Prakash","year":"2003","unstructured":"Prakash J, Velpandian T, Pande JN, Gupta SK. Serum rifampicin levels in patients with tuberculosis : Effect of P-Glycoprotein and CYP3A4 blockers on its absorption. Clin Drug Investig. 2003;23:463\u201372.","journal-title":"Clin Drug Investig"},{"key":"862_CR27","first-page":"374","volume":"14","author":"V Roy","year":"2010","unstructured":"Roy V, Gupta D, Gupta P, Sethi GR, Mishra TK. Pharmacokinetics of isoniazid in moderately malnourished children with tuberculosis. Int J Tuberc Lung Dis. 2010;14:374\u20136.","journal-title":"Int J Tuberc Lung Dis"},{"key":"862_CR28","first-page":"279","volume":"31","author":"V Seth","year":"1994","unstructured":"Seth V, Seth SD, Beotra A, Semwal OP, D\u2019monty V, Mukhopadhya S. Isoniazid and acetylisoniazid kinetics in serum and urine in pulmonary primary complex with intermittent regimen. Indian Pediatr. 1994;31:279\u201385.","journal-title":"Indian Pediatr"},{"key":"862_CR29","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1111\/tmi.12003","volume":"17","author":"LM Verhagen","year":"2012","unstructured":"Verhagen LM, L\u00f3pez D, Hermans PWM, Warris A, De Groot R, Garcia JF. Pharmacokinetics of anti-tuberculosis drugs in Venezuelan children younger than 16\u2003years of age: supportive evidence for the implementation of revised WHO dosing recommendations. Trop Med Int. 2012;17:1449\u201356.","journal-title":"Trop Med Int"},{"key":"862_CR30","first-page":"611","volume":"128","author":"DS Arya","year":"2008","unstructured":"Arya DS, Ojha SK, Semwal OP, Nandave M. Pharmacokinetics of pyrazinamide in children with primary progressive disease of lungs. Indian J Med Res. 2008;128:611\u20135.","journal-title":"Indian J Med Res"},{"key":"862_CR31","first-page":"287","volume":"33","author":"V Roy","year":"1996","unstructured":"Roy V, Tekur U, Chopra K. Pharmacokinetics of isoniazid in pulmonary tuberculosis\u2013a comparative study at two dose levels. Indian Pediatr. 1996;33:287\u201391.","journal-title":"Indian Pediatr"},{"key":"862_CR32","first-page":"133","volume":"3","author":"V Roy","year":"1999","unstructured":"Roy V, Tekur U, Chopra K. Pharmacokinetics of pyrazinamide in children suffering from pulmonary tuberculosis. Int J Tuberc Lung Dis. 1999;3:133\u20137.","journal-title":"Int J Tuberc Lung Dis"},{"key":"862_CR33","doi-asserted-by":"publisher","first-page":"5560","DOI":"10.1128\/AAC.05429-11","volume":"55","author":"S Thee","year":"2011","unstructured":"Thee S, Seddon JA, Donald PR, Seifart HI, Werely CJ, Hesseling AC. Pharmacokinetics of isoniazid, rifampin, and pyrazinamide in children younger than two years of age with tuberculosis: evidence for implementation of revised World Health Organization recommendations. Antimicrob Agents Chemother. 2011;55:5560\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"862_CR34","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.5897\/AJPP2012.0040","volume":"7","author":"M Ibrahim","year":"2013","unstructured":"Ibrahim M, Engidawork E, Yimer G, Bobosha K. Pharmacokinetics of isoniazid in Ethiopian children with tuberculosis in relation to the N-acetyltransferase 2 (NAT2) genotype. Afr J Pharm Pharmacol. 2013;7:1124\u201330.","journal-title":"Afr J Pharm Pharmacol"},{"key":"862_CR35","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/FTD.0b013e31825c4bc3","volume":"34","author":"JJ Kiser","year":"2012","unstructured":"Kiser JJ, Zhu R, D\u2019Argenio DZ, Cotton MF, Bobat R, McSherry GD. Isoniazid pharmacokinetics, pharmacodynamics, and dosing in South African infants. Ther Drug Monit. 2012;34:446\u201351.","journal-title":"Ther Drug Monit"},{"key":"862_CR36","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/jac\/dkt524","volume":"69","author":"SP Zvada","year":"2014","unstructured":"Zvada SP, Denti P, Donald PR, Schaaf HS, Thee S, Seddon JA. Population pharmacokinetics of rifampicin, pyrazinamide and isoniazid in children with tuberculosis: in silico evaluation of currently recommended doses. J Antimicrob Chemother. 2014;69:1339\u201349.","journal-title":"J Antimicrob Chemother"},{"key":"862_CR37","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1128\/AAC.01532-13","volume":"58","author":"A Bekker","year":"2014","unstructured":"Bekker A, Schaaf HS, Seifart HI, Draper HR, Werely CJ, Cotton MF. Pharmacokinetics of isoniazid in low-birth-weight and premature infants. Antimicrob Agents Chemother. 2014;58:2229\u201334.","journal-title":"Antimicrob Agents Chemother"},{"key":"862_CR38","doi-asserted-by":"crossref","unstructured":"Narang A, Roy RD, Chaurasia A, Mukhopadhyay A, Mukerji M, Dash D Indian Genome Variation Consortium, et al. IGVBrowser--a genomic variation resource from diverse Indian populations. Database 2010. doi:10.1093\/database\/baq022.","DOI":"10.1093\/database\/baq022"},{"key":"862_CR39","first-page":"125","volume":"11","author":"A Anitha","year":"2003","unstructured":"Anitha A, Banerjee M. Arylamine N-acetyltransferase 2 polymorphism in the ethnic populations of South India. Int J Mol Med. 2003;11:125\u201331.","journal-title":"Int J Mol Med"},{"key":"862_CR40","first-page":"259","volume":"22","author":"RC Gupta","year":"1984","unstructured":"Gupta RC, Nair CR, Jindal SK, Malik SK. Incidence of isoniazid acetylation phenotypes in North Indians. Int J Clin Pharmacol. 1984;22:259\u201364.","journal-title":"Int J Clin Pharmacol"},{"issue":"1","key":"862_CR41","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s12072-011-9309-4","volume":"6","author":"SV Rana","year":"2011","unstructured":"Rana SV, Ola RP, Sharma SK, Arora SK, Sinha SK, Pandhi P, et al. Comparison between acetylator phenotype and genotype polymorphism of n-acetyltransferase-2 in tuberculosis patients. Hepatol Int. 2011;6(1):397\u2013408.","journal-title":"Hepatol Int"},{"key":"862_CR42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2490-5-12","volume":"5","author":"DSL Srivastava","year":"2005","unstructured":"Srivastava DSL, Mittal RD. Genetic polymorphism of the N-acetyltransferase 2 gene, and susceptibility to prostate cancer: a pilot study in north Indian population. BMC Urol. 2005;5:12.","journal-title":"BMC Urol"},{"key":"862_CR43","volume-title":"Guidance for national tuberculosis programmes on the management of tuberculosis in children","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva, Switzerland: WHO; 2014."},{"key":"862_CR44","first-page":"1091","volume":"30","author":"V Seth","year":"1993","unstructured":"Seth V, Beotra A, Seth SD, Semwal OP, Kabra S, Jain Y. Serum concentrations of rifampicin and isoniazid in tuberculosis. Indian Pediatr. 1993;30:1091\u20138.","journal-title":"Indian Pediatr"},{"key":"862_CR45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ijpharm.2004.02.019","volume":"276","author":"S Agrawal","year":"2004","unstructured":"Agrawal S, Singh I, Kaur KJ, Bhade SR, Kaul CL, Panchagnula R. Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels. Int J Pharm. 2004;276:41\u20139.","journal-title":"Int J Pharm"},{"key":"862_CR46","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s13312-012-0164-8","volume":"49","author":"V Roy","year":"2012","unstructured":"Roy V, Sahni P, Gupta P, Sethi GR, Khanna A. Blood levels of pyrazinamide in children at doses administered under the Revised National Tuberculosis Control Program. Indian Pediatr. 2012;49:721\u20135.","journal-title":"Indian Pediatr"},{"key":"862_CR47","first-page":"1360","volume":"8","author":"M Zhu","year":"2004","unstructured":"Zhu M, Burman WJ, Starke JR, Stambaugh JJ, Steiner P, Bulpitt AE. Pharmacokinetics of ethambutol in children and adults with tuberculosis. Int J Tuberc Lung Dis. 2004;8:1360\u20137.","journal-title":"Int J Tuberc Lung Dis"},{"key":"862_CR48","first-page":"965","volume":"11","author":"S Thee","year":"2007","unstructured":"Thee S, Detjen A, Quarcoo D, Wahn U, Magdorf K. Ethambutol in paediatric tuberculosis: aspects of ethambutol serum concentration, efficacy and toxicity in children. Int J Tuberc Lung Dis. 2007;11:965\u201371.","journal-title":"Int J Tuberc Lung Dis"},{"key":"862_CR49","first-page":"1341","volume":"29","author":"V Seth","year":"1992","unstructured":"Seth V, Beotra A, Bagga A, Seth S. Drug therapy in malnutrition. Indian Pediatr. 1992;29:1341\u20136.","journal-title":"Indian Pediatr"},{"key":"862_CR50","first-page":"237","volume":"66","author":"Y Akbani","year":"1977","unstructured":"Akbani Y, Bolme P, Lindblad BS, Rahimtoola RJ. Control of streptomycin and isoniazid in malnourished children treated for tuberculosis. ActaPaediatrScand. 1977;66:237\u201340.","journal-title":"ActaPaediatrScand"},{"key":"862_CR51","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/02724936.1995.11747780","volume":"15","author":"HI Seifart","year":"1995","unstructured":"Seifart HI, Donald PR, De Villiers JN, Parkin DP, Jaarsveld PP. Isoniazid elimination kinetics in children with protein-energy malnutrition treated for tuberculous meningitis with a four-component antimicrobial regimen. Ann Trop Paediatr. 1995;15:249\u201354.","journal-title":"Ann Trop Paediatr"},{"key":"862_CR52","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/j.1651-2227.1988.tb10774.x","volume":"77","author":"M Eriksson","year":"1988","unstructured":"Eriksson M, Bolme P, Habte D, Paalzow L. INH and streptomycin in Ethiopian children with tuberculosis and different nutritional status. Acta Paediatr Scand. 1988;77:890\u20134.","journal-title":"Acta Paediatr Scand"},{"key":"862_CR53","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1164\/arrd.1977.116.4.627","volume":"116","author":"JM Dickinson","year":"1977","unstructured":"Dickinson JM, Aber VR, Mitchison DA. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis. Am Rev Respir Dis. 1977;116:627\u201335.","journal-title":"Am Rev Respir Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-015-0862-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0862-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0862-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0862-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T09:29:28Z","timestamp":1630574968000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-0862-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,14]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["862"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-0862-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,14]]},"assertion":[{"value":"5 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"126"}}